BSX to Pay J&J $703M in Stent Suit

Xconomy Boston — 

Boston Scientific (NYSE:BSX), a Natick, MA-based medical devices maker, has been ordered to pay $703 million to the Cordis unit of medical products giant Johnson & Johnson for infringing on a Cordis patent on stents, according to J&J. The U.S. District Court of Delaware made a final judgment in the case that also involved Minneapolis-based medical devices firm Medtronic, which was ordered to pay Cordis $521 million.